-- Novel approach to gene knockdown uses proprietary CASi (Conditionally Activated siRNA) molecules optimized to “switch” on, activating siRNA therapeutics only in selected cells -- -- CASi platform, ...
Report covers Silexion Therapeutics (NASDAQ: SLXN), a disruptive player in the precision oncology space, developing innovative RNAi therapies targeting KRAS-driven cancers, highlighting the company’s ...
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is one of the most promising healthcare stocks according to Wall Street analysts. On June 10, GENESIS Pharma announced the expansion of its commercial ...
Agriculture is fundamental to ensuring humanity’s food and fibre security. Synthetic pesticides pose challenges due to resistance, emissions, toxicity, and harm to beneficial organisms. A novel ...
Scientists created a programmable RNA repair tool that selectively replaces harmful RNA regions while preserving healthy ...
Inside Philadelphia’s new RNA manufacturing hub, scientists are working to create vaccines for fish, precision pesticides and treatments to protect plants from extreme heat. The recently launched ...
Univeristy of Nebraska-Lincoln (UNL) scientist Ana Maria Vélez is pioneering a genetic treatment to contain western corn rootworm. The research seeks to contain agricultural pests by targeting ...
Ribonucleic acid, also called RNA, is a molecule present in all living cells. It plays a critical role in transmitting genetic instructions from DNA and creating proteins. With the power to execute a ...
LONDON--(BUSINESS WIRE)--Silexion Therapeutics (NASDAQ: SLXN) has emerged an intriguing yet under the radar player in the precision oncology space, focusing on developing innovative RNA interference ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results